About
Nanobiotix S.a (NASDAQ:NBTX) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology
Mar 31 2026
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
Mar 30 2026
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
Mar 26 2026
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026
Mar 25 2026
NANOBIOTIX Statement Regarding Recent Media Speculation
Financials
Revenue
$32.59 M
Market Cap
$1.5 B
EPS
-0.58
Translate